Systemic Symptoms and Physical Features
At a Glance
Mulibrey nanism is a multisystemic condition that affects bone development, facial features, internal organs, and the immune system. Children with the condition often have a triangular face, higher risk of bone fractures, liver enlargement, and are prone to recurrent respiratory infections.
While the most critical aspects of Mulibrey nanism are growth and heart health, the condition is “multisystemic,” meaning it can affect many different parts of your child’s body [1][2]. Understanding these physical features can help you and your medical team monitor your child’s health more comprehensively.
Distinctive Facial and Skeletal Features
Many children with Mulibrey nanism share a similar “look.” These features are caused by the way the TRIM37 gene affects the development of bone and cartilage [3][4].
- Facial Appearance: Common features include a triangular-shaped face, a prominent or bulging forehead, and a low bridge of the nose [5][6]. Your child may also have a high-pitched, sometimes “squeaky” voice [5].
- Bone Structure: The long bones (like those in the arms and legs) are often slender and may have a slight bow [2]. Inside the bone, the walls (cortex) may be unusually thick while the center (medullary cavity) is narrow [2].
- Spine and Sella Turcica: The bones of the spine (vertebrae) may appear taller than average on an X-ray [2]. Additionally, a specific structure at the base of the brain called the sella turcica—which holds the pituitary gland—often has a distinctive “J-shape” in children with this condition [5].
- Fracture Risk and Activity: Because of these structural differences, about half of children with Mulibrey nanism may experience bone fractures or develop fibrous dysplasia (a condition where normal bone is replaced by fibrous tissue) [2]. Due to this fracture risk and underlying heart considerations, you will need to discuss safe levels of physical activity, recess, and sports with your medical team. Children are encouraged to stay active, but certain high-impact activities may need to be avoided.
The Eyes and Brain
Two very specific signs can help doctors confirm a diagnosis of Mulibrey nanism during a physical exam:
- Yellowish Eye Spots: During a dilated eye exam, an ophthalmologist may see small, yellowish-white dots in the fundus (the back of the eye) [5][7]. These spots do not usually affect vision, but they are a hallmark sign of the condition [5].
- Brain Variations: Besides the J-shaped sella turcica, some children may have slightly enlarged ventricles (the fluid-filled spaces in the brain) [5][8]. As mentioned, these structural differences do not typically impact cognitive intelligence.
Internal Organ Involvement
The “LI” in the Mulibrey acronym stands for the liver, but other organs are involved as well:
- Liver (Hepatopathy): The liver can become enlarged (hepatomegaly) and may develop scarring (fibrosis) or fatty changes [9][10]. Monitoring liver health is vital, as it is one of the major factors in a child’s long-term outlook [9][7].
- Kidneys: While kidney function is usually normal, some children may develop small cysts or have an increased risk of Wilms tumor, a rare kidney cancer that is highly treatable if caught early through regular ultrasounds [11][12].
The Immune System and Infections
Recent research has shown that the TRIM37 gene also plays a role in how the body fights off germs [1][13].
- Frequent Infections: Many children with Mulibrey nanism experience recurrent respiratory infections, such as pneumonia or severe colds [1][13].
- Antibody Levels: Some children may have hypogammaglobulinemia, which is a fancy way of saying they have low levels of the antibodies (the body’s “defense soldiers”) needed to fight infection [13][14].
- T-Cell Differences: There may also be variations in the types of T-cells (a type of white blood cell) in their blood, which can make it harder for their immune system to “remember” and fight certain viruses [1][13].
Monitoring these features through regular check-ups allows you to stay one step ahead, ensuring your child receives support for their bones, eyes, and immune system as they grow.
Common questions in this guide
What facial features are common in children with Mulibrey nanism?
Why do children with Mulibrey nanism have a higher risk of bone fractures?
What specific eye changes occur in Mulibrey nanism?
How does Mulibrey nanism affect the liver and kidneys?
Does Mulibrey nanism affect the immune system?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my child have signs of 'fibrous dysplasia' or other skeletal changes that increase their risk of fractures?
- 2.Is a J-shaped sella turcica visible on my child's brain imaging, and what does that mean for their pituitary function?
- 3.Should we check my child's immunoglobulin (IgG) levels to see if they need extra support for their immune system?
- 4.What specific changes did the ophthalmologist see in the 'fundus' of my child’s eyes?
- 5.What level of physical activity or sports is safe for my child given their bone and heart health?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
The TRIM37 variants in Mulibrey nanism patients paralyze follicular helper T cell differentiation.
Gu W, Zhang J, Li Q, et al.
Cell discovery 2023; (9(1)):82 doi:10.1038/s41421-023-00561-z.
PMID: 37528081 - 2
Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia.
Karlberg S, Toiviainen-Salo S, Lipsanen-Nyman M, Mäkitie O
Clinical genetics 2025; (107(3)):271-277 doi:10.1111/cge.14647.
PMID: 39558672 - 3
A proteomic study of the downregulation of TRIM37 on chondrocytes: Implications for the MULIBREY syndrome.
Brigant B, Metzinger-Le Meuth V, Boyartchuk V, et al.
Bone 2024; (187()):117205 doi:10.1016/j.bone.2024.117205.
PMID: 39019132 - 4
TRIM37 is highly expressed during mitosis in CHON-002 chondrocytes cell line and is regulated by miR-223.
Brigant B, Demont Y, Ouled-Haddou H, et al.
Bone 2020; (137()):115393 doi:10.1016/j.bone.2020.115393.
PMID: 32353567 - 5
Report of two Syrian siblings with Mulibrey nanism.
Al Saadi T, Alkhatib M, Turk T, et al.
Oxford medical case reports 2015; (2015(12)):367-70 doi:10.1093/omcr/omv065.
PMID: 26664725 - 6
Whole Exome Sequencing Identified the Causative Mutation in a 4-Year-Old Female with Mulibrey Nanism: A Case Report.
Zeinaloo AA, Mirzaei Ilali H, Aghaei Moghadam E, et al.
Iranian journal of public health 2022; (51(12)):2826-2830 doi:10.18502/ijph.v51i12.11474.
PMID: 36742244 - 7
The Importance of Early Pericardiectomy in Mulibrey Nanism Syndrome, a Case Report.
Cordova Sanchez A, Vasigh M, Carhart R
Journal of investigative medicine high impact case reports 2022; (10()):23247096221077816 doi:10.1177/23247096221077816.
PMID: 35257621 - 8
TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism.
Brigant B, Metzinger-Le Meuth V, Rochette J, Metzinger L
International journal of molecular sciences 2018; (20(1)) doi:10.3390/ijms20010067.
PMID: 30586926 - 9
Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism).
Sivunen J, Karlberg S, Kivisaari R, et al.
Liver international : official journal of the International Association for the Study of the Liver 2022; (42(6)):1369-1378 doi:10.1111/liv.15213.
PMID: 35220664 - 10
Mulibrey nanism: Two novel mutations in a child identified by Array CGH and DNA sequencing.
Mozzillo E, Cozzolino C, Genesio R, et al.
American journal of medical genetics. Part A 2016; (170(8)):2196-9 doi:10.1002/ajmg.a.37770.
PMID: 27256967 - 11
Wilms tumor with Mulibrey Nanism: A case report and review of literature.
Upasana K, Thakkar D, Gautam D, et al.
Cancer reports (Hoboken, N.J.) 2022; (5(5)):e1512 doi:10.1002/cnr2.1512.
PMID: 34309235 - 12
Renal findings in patients with Mulibrey nanism.
Sivunen J, Karlberg S, Lohi J, et al.
Pediatric nephrology (Berlin, Germany) 2017; (32(9)):1531-1536 doi:10.1007/s00467-017-3669-5.
PMID: 28432469 - 13
Mulibrey nanism and immunological complications: a comprehensive case report and literature review.
Gazzin A, Pala F, Bosticardo M, et al.
Frontiers in immunology 2023; (14()):1303251 doi:10.3389/fimmu.2023.1303251.
PMID: 38116000 - 14
CD4+ T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations.
Bruzzaniti S, Cirillo E, Prencipe R, et al.
Frontiers in immunology 2020; (11()):1742 doi:10.3389/fimmu.2020.01742.
PMID: 33042106
This page explains the systemic symptoms and physical features of Mulibrey nanism for educational purposes. Always consult your child's pediatric specialist or medical team for proper monitoring and individualized care.
Get notified when new evidence is published on Mulibrey nanism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.